HAMBURG (dpa-AFX) - Monday, Evotec SE (EVO) announced the expansion of the
strategic partnership of its biologics segment Just-Evotec Biologics, Inc. with
Sandoz Group AG (SDZNY) for the development and commercial manufacturing of
biosimilars.

The company stated that this enhanced collaboration reinforces Just-Evotec
Biologics' dedication to delivering ongoing commercial biosimilar supply to
Sandoz from its newly constructed J.POD biologics manufacturing facility at
Evotec's Campus Curie in Toulouse, France.

Within this agreement, Sandoz obtains additional assurances regarding long-term
supply for patients while reserving a significant commercial manufacturing
capacity.



Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX